nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Decitabine—Gemcitabine—pancreatic cancer	0.731	1	CrCrCtD
Telbivudine—Floxuridine—TYMP—pancreatic cancer	0.00416	0.314	CrCbGaD
Telbivudine—Trifluridine—TYMP—pancreatic cancer	0.0033	0.249	CrCbGaD
Telbivudine—Zidovudine—TERT—pancreatic cancer	0.00229	0.173	CrCbGaD
Telbivudine—Floxuridine—TYMS—pancreatic cancer	0.00195	0.147	CrCbGaD
Telbivudine—Trifluridine—TYMS—pancreatic cancer	0.00155	0.117	CrCbGaD
Telbivudine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000415	0.00162	CcSEcCtD
Telbivudine—Fatigue—Sunitinib—pancreatic cancer	0.000414	0.00162	CcSEcCtD
Telbivudine—Cough—Gemcitabine—pancreatic cancer	0.000412	0.00161	CcSEcCtD
Telbivudine—Pain—Sunitinib—pancreatic cancer	0.000411	0.00161	CcSEcCtD
Telbivudine—Discomfort—Irinotecan—pancreatic cancer	0.000408	0.00159	CcSEcCtD
Telbivudine—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000406	0.00159	CcSEcCtD
Telbivudine—Asthenia—Tamoxifen—pancreatic cancer	0.000403	0.00157	CcSEcCtD
Telbivudine—Chest pain—Gemcitabine—pancreatic cancer	0.000402	0.00157	CcSEcCtD
Telbivudine—Arthralgia—Gemcitabine—pancreatic cancer	0.000402	0.00157	CcSEcCtD
Telbivudine—Myalgia—Gemcitabine—pancreatic cancer	0.000402	0.00157	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.0004	0.00156	CcSEcCtD
Telbivudine—Asthenia—Erlotinib—pancreatic cancer	0.000398	0.00156	CcSEcCtD
Telbivudine—Discomfort—Gemcitabine—pancreatic cancer	0.000397	0.00155	CcSEcCtD
Telbivudine—Pruritus—Tamoxifen—pancreatic cancer	0.000397	0.00155	CcSEcCtD
Telbivudine—Chest pain—Fluorouracil—pancreatic cancer	0.000396	0.00155	CcSEcCtD
Telbivudine—Myalgia—Fluorouracil—pancreatic cancer	0.000396	0.00155	CcSEcCtD
Telbivudine—Renal impairment—Epirubicin—pancreatic cancer	0.000395	0.00154	CcSEcCtD
Telbivudine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000393	0.00154	CcSEcCtD
Telbivudine—Pruritus—Erlotinib—pancreatic cancer	0.000393	0.00153	CcSEcCtD
Telbivudine—Discomfort—Fluorouracil—pancreatic cancer	0.000391	0.00153	CcSEcCtD
Telbivudine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000388	0.00152	CcSEcCtD
Telbivudine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000388	0.00151	CcSEcCtD
Telbivudine—Hepatitis—Docetaxel—pancreatic cancer	0.000385	0.0015	CcSEcCtD
Telbivudine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000384	0.0015	CcSEcCtD
Telbivudine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000383	0.0015	CcSEcCtD
Telbivudine—Pharyngitis—Docetaxel—pancreatic cancer	0.000382	0.00149	CcSEcCtD
Telbivudine—Body temperature increased—Sunitinib—pancreatic cancer	0.00038	0.00148	CcSEcCtD
Telbivudine—Abdominal pain—Sunitinib—pancreatic cancer	0.00038	0.00148	CcSEcCtD
Telbivudine—Diarrhoea—Erlotinib—pancreatic cancer	0.00038	0.00148	CcSEcCtD
Telbivudine—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000379	0.00148	CcSEcCtD
Telbivudine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000378	0.00148	CcSEcCtD
Telbivudine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000378	0.00147	CcSEcCtD
Telbivudine—Pain in extremity—Epirubicin—pancreatic cancer	0.000376	0.00147	CcSEcCtD
Telbivudine—Skin disorder—Gemcitabine—pancreatic cancer	0.000375	0.00146	CcSEcCtD
Telbivudine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000372	0.00145	CcSEcCtD
Telbivudine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000371	0.00145	CcSEcCtD
Telbivudine—Dizziness—Tamoxifen—pancreatic cancer	0.000371	0.00145	CcSEcCtD
Telbivudine—Migraine—Epirubicin—pancreatic cancer	0.00037	0.00144	CcSEcCtD
Telbivudine—Dizziness—Erlotinib—pancreatic cancer	0.000367	0.00143	CcSEcCtD
Telbivudine—Renal impairment—Doxorubicin—pancreatic cancer	0.000365	0.00143	CcSEcCtD
Telbivudine—Insomnia—Irinotecan—pancreatic cancer	0.000358	0.0014	CcSEcCtD
Telbivudine—Vomiting—Tamoxifen—pancreatic cancer	0.000357	0.00139	CcSEcCtD
Telbivudine—Paraesthesia—Irinotecan—pancreatic cancer	0.000355	0.00139	CcSEcCtD
Telbivudine—Rash—Tamoxifen—pancreatic cancer	0.000354	0.00138	CcSEcCtD
Telbivudine—Dermatitis—Tamoxifen—pancreatic cancer	0.000353	0.00138	CcSEcCtD
Telbivudine—Vomiting—Erlotinib—pancreatic cancer	0.000353	0.00138	CcSEcCtD
Telbivudine—Headache—Tamoxifen—pancreatic cancer	0.000352	0.00137	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000351	0.00137	CcSEcCtD
Telbivudine—Rash—Erlotinib—pancreatic cancer	0.00035	0.00137	CcSEcCtD
Telbivudine—Dermatitis—Erlotinib—pancreatic cancer	0.00035	0.00137	CcSEcCtD
Telbivudine—Insomnia—Gemcitabine—pancreatic cancer	0.000349	0.00136	CcSEcCtD
Telbivudine—Dyspepsia—Irinotecan—pancreatic cancer	0.000348	0.00136	CcSEcCtD
Telbivudine—Headache—Erlotinib—pancreatic cancer	0.000348	0.00136	CcSEcCtD
Telbivudine—Pain in extremity—Doxorubicin—pancreatic cancer	0.000348	0.00136	CcSEcCtD
Telbivudine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000347	0.00136	CcSEcCtD
Telbivudine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000346	0.00135	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000345	0.00135	CcSEcCtD
Telbivudine—Asthenia—Sunitinib—pancreatic cancer	0.000345	0.00135	CcSEcCtD
Telbivudine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000343	0.00134	CcSEcCtD
Telbivudine—Insomnia—Fluorouracil—pancreatic cancer	0.000343	0.00134	CcSEcCtD
Telbivudine—Migraine—Doxorubicin—pancreatic cancer	0.000342	0.00134	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000342	0.00134	CcSEcCtD
Telbivudine—Fatigue—Irinotecan—pancreatic cancer	0.000341	0.00133	CcSEcCtD
Telbivudine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00034	0.00133	CcSEcCtD
Telbivudine—Pruritus—Sunitinib—pancreatic cancer	0.00034	0.00133	CcSEcCtD
Telbivudine—Pain—Irinotecan—pancreatic cancer	0.000339	0.00132	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000338	0.00132	CcSEcCtD
Telbivudine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000336	0.00131	CcSEcCtD
Telbivudine—Malnutrition—Docetaxel—pancreatic cancer	0.000335	0.00131	CcSEcCtD
Telbivudine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000334	0.0013	CcSEcCtD
Telbivudine—Nausea—Tamoxifen—pancreatic cancer	0.000333	0.0013	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000333	0.0013	CcSEcCtD
Telbivudine—Fatigue—Gemcitabine—pancreatic cancer	0.000332	0.0013	CcSEcCtD
Telbivudine—Gastritis—Epirubicin—pancreatic cancer	0.000332	0.0013	CcSEcCtD
Telbivudine—Muscular weakness—Epirubicin—pancreatic cancer	0.000331	0.00129	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000331	0.00129	CcSEcCtD
Telbivudine—Pain—Gemcitabine—pancreatic cancer	0.00033	0.00129	CcSEcCtD
Telbivudine—Nausea—Erlotinib—pancreatic cancer	0.00033	0.00129	CcSEcCtD
Telbivudine—Diarrhoea—Sunitinib—pancreatic cancer	0.000329	0.00128	CcSEcCtD
Telbivudine—Dysgeusia—Docetaxel—pancreatic cancer	0.000328	0.00128	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000327	0.00128	CcSEcCtD
Telbivudine—Abdominal distension—Epirubicin—pancreatic cancer	0.000327	0.00128	CcSEcCtD
Telbivudine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000326	0.00127	CcSEcCtD
Telbivudine—Influenza—Epirubicin—pancreatic cancer	0.000325	0.00127	CcSEcCtD
Telbivudine—Back pain—Docetaxel—pancreatic cancer	0.000324	0.00127	CcSEcCtD
Telbivudine—Pain—Fluorouracil—pancreatic cancer	0.000324	0.00127	CcSEcCtD
Telbivudine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000324	0.00126	CcSEcCtD
Telbivudine—Muscle spasms—Docetaxel—pancreatic cancer	0.000322	0.00126	CcSEcCtD
Telbivudine—Dizziness—Sunitinib—pancreatic cancer	0.000318	0.00124	CcSEcCtD
Telbivudine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000318	0.00124	CcSEcCtD
Telbivudine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000317	0.00124	CcSEcCtD
Telbivudine—Abdominal pain—Irinotecan—pancreatic cancer	0.000313	0.00122	CcSEcCtD
Telbivudine—Body temperature increased—Irinotecan—pancreatic cancer	0.000313	0.00122	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000313	0.00122	CcSEcCtD
Telbivudine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000312	0.00122	CcSEcCtD
Telbivudine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000311	0.00121	CcSEcCtD
Telbivudine—Gastritis—Doxorubicin—pancreatic cancer	0.000308	0.0012	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000306	0.0012	CcSEcCtD
Telbivudine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000306	0.0012	CcSEcCtD
Telbivudine—Vomiting—Sunitinib—pancreatic cancer	0.000306	0.00119	CcSEcCtD
Telbivudine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000305	0.00119	CcSEcCtD
Telbivudine—Neutropenia—Epirubicin—pancreatic cancer	0.000304	0.00119	CcSEcCtD
Telbivudine—Rash—Sunitinib—pancreatic cancer	0.000303	0.00118	CcSEcCtD
Telbivudine—Dermatitis—Sunitinib—pancreatic cancer	0.000303	0.00118	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—pancreatic cancer	0.000302	0.00118	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000302	0.00118	CcSEcCtD
Telbivudine—Headache—Sunitinib—pancreatic cancer	0.000301	0.00118	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—pancreatic cancer	0.0003	0.00117	CcSEcCtD
Telbivudine—Body temperature increased—Fluorouracil—pancreatic cancer	0.0003	0.00117	CcSEcCtD
Telbivudine—Cough—Docetaxel—pancreatic cancer	0.000293	0.00114	CcSEcCtD
Telbivudine—Myalgia—Docetaxel—pancreatic cancer	0.000285	0.00112	CcSEcCtD
Telbivudine—Arthralgia—Docetaxel—pancreatic cancer	0.000285	0.00112	CcSEcCtD
Telbivudine—Chest pain—Docetaxel—pancreatic cancer	0.000285	0.00112	CcSEcCtD
Telbivudine—Nausea—Sunitinib—pancreatic cancer	0.000285	0.00112	CcSEcCtD
Telbivudine—Renal failure—Epirubicin—pancreatic cancer	0.000285	0.00111	CcSEcCtD
Telbivudine—Asthenia—Irinotecan—pancreatic cancer	0.000284	0.00111	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000284	0.00111	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000284	0.00111	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—pancreatic cancer	0.000281	0.0011	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000279	0.00109	CcSEcCtD
Telbivudine—Asthenia—Gemcitabine—pancreatic cancer	0.000277	0.00108	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000274	0.00107	CcSEcCtD
Telbivudine—Pruritus—Gemcitabine—pancreatic cancer	0.000273	0.00107	CcSEcCtD
Telbivudine—Diarrhoea—Irinotecan—pancreatic cancer	0.000271	0.00106	CcSEcCtD
Telbivudine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000268	0.00105	CcSEcCtD
Telbivudine—Pruritus—Fluorouracil—pancreatic cancer	0.000268	0.00105	CcSEcCtD
Telbivudine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000268	0.00105	CcSEcCtD
Telbivudine—Skin disorder—Docetaxel—pancreatic cancer	0.000266	0.00104	CcSEcCtD
Telbivudine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000264	0.00103	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—pancreatic cancer	0.000263	0.00103	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000263	0.00103	CcSEcCtD
Telbivudine—Dizziness—Irinotecan—pancreatic cancer	0.000262	0.00102	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—pancreatic cancer	0.00026	0.00101	CcSEcCtD
Telbivudine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000259	0.00101	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000259	0.00101	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—pancreatic cancer	0.000258	0.00101	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000255	0.000997	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000253	0.000989	CcSEcCtD
Telbivudine—Vomiting—Irinotecan—pancreatic cancer	0.000252	0.000983	CcSEcCtD
Telbivudine—Dizziness—Fluorouracil—pancreatic cancer	0.000251	0.000979	CcSEcCtD
Telbivudine—Rash—Irinotecan—pancreatic cancer	0.00025	0.000975	CcSEcCtD
Telbivudine—Dermatitis—Irinotecan—pancreatic cancer	0.000249	0.000974	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000249	0.000974	CcSEcCtD
Telbivudine—Headache—Irinotecan—pancreatic cancer	0.000248	0.000969	CcSEcCtD
Telbivudine—Insomnia—Docetaxel—pancreatic cancer	0.000248	0.000967	CcSEcCtD
Telbivudine—Paraesthesia—Docetaxel—pancreatic cancer	0.000246	0.00096	CcSEcCtD
Telbivudine—Vomiting—Gemcitabine—pancreatic cancer	0.000245	0.000958	CcSEcCtD
Telbivudine—Rash—Gemcitabine—pancreatic cancer	0.000243	0.00095	CcSEcCtD
Telbivudine—Dermatitis—Gemcitabine—pancreatic cancer	0.000243	0.000949	CcSEcCtD
Telbivudine—Headache—Gemcitabine—pancreatic cancer	0.000242	0.000944	CcSEcCtD
Telbivudine—Vomiting—Fluorouracil—pancreatic cancer	0.000241	0.000942	CcSEcCtD
Telbivudine—Dyspepsia—Docetaxel—pancreatic cancer	0.000241	0.000941	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—pancreatic cancer	0.00024	0.000939	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000239	0.000934	CcSEcCtD
Telbivudine—Rash—Fluorouracil—pancreatic cancer	0.000239	0.000934	CcSEcCtD
Telbivudine—Dermatitis—Fluorouracil—pancreatic cancer	0.000239	0.000933	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000239	0.000932	CcSEcCtD
Telbivudine—Headache—Fluorouracil—pancreatic cancer	0.000238	0.000928	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000236	0.000923	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000236	0.000923	CcSEcCtD
Telbivudine—Fatigue—Docetaxel—pancreatic cancer	0.000236	0.000922	CcSEcCtD
Telbivudine—Nausea—Irinotecan—pancreatic cancer	0.000235	0.000919	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000234	0.000915	CcSEcCtD
Telbivudine—Pain—Docetaxel—pancreatic cancer	0.000234	0.000914	CcSEcCtD
Telbivudine—Nausea—Gemcitabine—pancreatic cancer	0.000229	0.000895	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—pancreatic cancer	0.000226	0.000884	CcSEcCtD
Telbivudine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000226	0.000881	CcSEcCtD
Telbivudine—Nausea—Fluorouracil—pancreatic cancer	0.000225	0.00088	CcSEcCtD
Telbivudine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000224	0.000874	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—pancreatic cancer	0.000221	0.000865	CcSEcCtD
Telbivudine—Back pain—Epirubicin—pancreatic cancer	0.000219	0.000855	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—pancreatic cancer	0.000217	0.000849	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000217	0.000846	CcSEcCtD
Telbivudine—Abdominal pain—Docetaxel—pancreatic cancer	0.000216	0.000845	CcSEcCtD
Telbivudine—Body temperature increased—Docetaxel—pancreatic cancer	0.000216	0.000845	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00021	0.00082	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—pancreatic cancer	0.000209	0.000817	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000205	0.000801	CcSEcCtD
Telbivudine—Malaise—Epirubicin—pancreatic cancer	0.000204	0.000797	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—pancreatic cancer	0.000202	0.000791	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000201	0.000786	CcSEcCtD
Telbivudine—Cough—Epirubicin—pancreatic cancer	0.000197	0.000771	CcSEcCtD
Telbivudine—Asthenia—Docetaxel—pancreatic cancer	0.000196	0.000767	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000194	0.000759	CcSEcCtD
Telbivudine—Pruritus—Docetaxel—pancreatic cancer	0.000194	0.000756	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—pancreatic cancer	0.000193	0.000752	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—pancreatic cancer	0.000193	0.000752	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—pancreatic cancer	0.000193	0.000752	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000191	0.000747	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—pancreatic cancer	0.00019	0.000743	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—pancreatic cancer	0.000189	0.000737	CcSEcCtD
Telbivudine—Diarrhoea—Docetaxel—pancreatic cancer	0.000187	0.000731	CcSEcCtD
Telbivudine—Cough—Doxorubicin—pancreatic cancer	0.000183	0.000713	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000181	0.000707	CcSEcCtD
Telbivudine—Dizziness—Docetaxel—pancreatic cancer	0.000181	0.000707	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000181	0.000706	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—pancreatic cancer	0.000179	0.0007	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—pancreatic cancer	0.000178	0.000696	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—pancreatic cancer	0.000178	0.000696	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—pancreatic cancer	0.000178	0.000696	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000177	0.000691	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—pancreatic cancer	0.000176	0.000688	CcSEcCtD
Telbivudine—Vomiting—Docetaxel—pancreatic cancer	0.000174	0.00068	CcSEcCtD
Telbivudine—Rash—Docetaxel—pancreatic cancer	0.000173	0.000674	CcSEcCtD
Telbivudine—Dermatitis—Docetaxel—pancreatic cancer	0.000172	0.000673	CcSEcCtD
Telbivudine—Headache—Docetaxel—pancreatic cancer	0.000171	0.00067	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000168	0.000657	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000167	0.000654	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000167	0.000653	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—pancreatic cancer	0.000167	0.000652	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—pancreatic cancer	0.000166	0.000648	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—pancreatic cancer	0.000166	0.000647	CcSEcCtD
Telbivudine—Nausea—Docetaxel—pancreatic cancer	0.000163	0.000635	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—pancreatic cancer	0.000162	0.000635	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000159	0.000623	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—pancreatic cancer	0.000159	0.000622	CcSEcCtD
Telbivudine—Pain—Epirubicin—pancreatic cancer	0.000158	0.000617	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000156	0.000608	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—pancreatic cancer	0.000154	0.000603	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000153	0.000599	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000152	0.000594	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000151	0.00059	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—pancreatic cancer	0.00015	0.000587	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000147	0.000576	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—pancreatic cancer	0.000147	0.000575	CcSEcCtD
Telbivudine—Pain—Doxorubicin—pancreatic cancer	0.000146	0.000571	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—pancreatic cancer	0.000146	0.00057	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—pancreatic cancer	0.000146	0.00057	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000141	0.00055	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00014	0.000546	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.000527	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.000527	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—pancreatic cancer	0.000132	0.000517	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—pancreatic cancer	0.000131	0.00051	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—pancreatic cancer	0.000126	0.000493	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—pancreatic cancer	0.000123	0.000479	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.000477	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—pancreatic cancer	0.000121	0.000472	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—pancreatic cancer	0.000117	0.000458	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000117	0.000456	CcSEcCtD
Telbivudine—Rash—Epirubicin—pancreatic cancer	0.000116	0.000455	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—pancreatic cancer	0.000116	0.000454	CcSEcCtD
Telbivudine—Headache—Epirubicin—pancreatic cancer	0.000116	0.000452	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000441	CcSEcCtD
Telbivudine—Nausea—Epirubicin—pancreatic cancer	0.00011	0.000428	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—pancreatic cancer	0.000109	0.000424	CcSEcCtD
Telbivudine—Rash—Doxorubicin—pancreatic cancer	0.000108	0.000421	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—pancreatic cancer	0.000108	0.00042	CcSEcCtD
Telbivudine—Headache—Doxorubicin—pancreatic cancer	0.000107	0.000418	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—pancreatic cancer	0.000101	0.000396	CcSEcCtD
